Co-Authors
This is a "connection" page, showing publications co-authored by Bruno Mégarbane and Alain Stépanian.
Connection Strength
1.246
-
von Willebrand factor/ADAMTS13 axis and venous thromboembolism in moderate-to-severe COVID-19 patients. Br J Haematol. 2021 03; 192(6):1097-1100.
Score: 0.230
-
Contrast between Prevalence of HIT Antibodies and Confirmed HIT in Hospitalized COVID-19 Patients: A Prospective Study with Clinical Implications. Thromb Haemost. 2021 07; 121(7):971-975.
Score: 0.229
-
Imbalance between procoagulant factors and natural coagulation inhibitors contributes to hypercoagulability in the critically ill COVID-19 patient: clinical implications. Eur Rev Med Pharmacol Sci. 2020 Sep; 24(17):9161-9168.
Score: 0.225
-
Are antiphospholipid antibodies associated with thrombotic complications in critically ill COVID-19 patients? Thromb Res. 2020 11; 195:74-76.
Score: 0.223
-
High Prevalence of Deep Vein Thrombosis in Mechanically Ventilated COVID-19 Patients. J Am Coll Cardiol. 2020 Jul 28; 76(4):480-482.
Score: 0.221
-
Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths. Sci Immunol. 2021 08 19; 6(62).
Score: 0.060
-
Pathophysiological Processes Underlying the High Prevalence of Deep Vein Thrombosis in Critically Ill COVID-19 Patients. Front Physiol. 2020; 11:608788.
Score: 0.058